JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,898,514 | +115.1% | 2,107,305 | +29.0% | 0.00% | – |
| Q4 2022 | $1,812,827 | -52.3% | 1,633,178 | +0.5% | 0.00% | – |
| Q3 2022 | $3,804,000 | -21.7% | 1,625,857 | +1.4% | 0.00% | – |
| Q2 2022 | $4,857,000 | -55.7% | 1,602,974 | -0.7% | 0.00% | – |
| Q1 2022 | $10,956,000 | -17.6% | 1,613,505 | +1.3% | 0.00% | – |
| Q4 2021 | $13,294,000 | +24.0% | 1,592,032 | +10.3% | 0.00% | – |
| Q3 2021 | $10,725,000 | +12.1% | 1,443,429 | +2.6% | 0.00% | – |
| Q2 2021 | $9,566,000 | -31.6% | 1,406,825 | +3.4% | 0.00% | – |
| Q1 2021 | $13,976,000 | +121.6% | 1,360,765 | +51.0% | 0.00% | – |
| Q4 2020 | $6,307,000 | -14.4% | 901,060 | -0.2% | 0.00% | – |
| Q3 2020 | $7,368,000 | +8.6% | 902,992 | -8.1% | 0.00% | – |
| Q2 2020 | $6,782,000 | +41.1% | 982,863 | -2.9% | 0.00% | – |
| Q1 2020 | $4,806,000 | -41.4% | 1,011,825 | +7.7% | 0.00% | – |
| Q4 2019 | $8,202,000 | +184.9% | 939,538 | +8.7% | 0.00% | – |
| Q3 2019 | $2,879,000 | -27.3% | 864,688 | +8.1% | 0.00% | – |
| Q2 2019 | $3,961,000 | +4.5% | 800,150 | +30.8% | 0.00% | – |
| Q1 2019 | $3,792,000 | +135.5% | 611,610 | +28.0% | 0.00% | – |
| Q4 2018 | $1,610,000 | -68.1% | 477,871 | -38.4% | 0.00% | – |
| Q3 2018 | $5,045,000 | -10.3% | 776,016 | +5.7% | 0.00% | – |
| Q2 2018 | $5,623,000 | -58.5% | 734,071 | +21.1% | 0.00% | -100.0% |
| Q1 2018 | $13,545,000 | +60.2% | 606,071 | -8.6% | 0.00% | – |
| Q4 2017 | $8,453,000 | -6.3% | 662,932 | +14.5% | 0.00% | – |
| Q3 2017 | $9,024,000 | +152.2% | 579,160 | +127.1% | 0.00% | – |
| Q2 2017 | $3,578,000 | +42.8% | 255,060 | +123.8% | 0.00% | – |
| Q1 2017 | $2,506,000 | – | 113,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |